Wire Stories
741AM Best Revises Outlooks to Negative For Dhipaya Insurance Public Company Limited
SINGAPORE–(BUSINESS WIRE)–AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating of A- (Excellent) and the...
- 672
India Live Event Market Report 2020: Ticketed Events, Event Category, Future Outlook, Event Offerings in Percent – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Live Event Market, Ticketed Events, Event Category, Future Outlook, Event Offerings in Percent” report has been added to ResearchAndMarkets.com’s...
- 750
Kulicke & Soffa Declares Regular Quarterly Dividend of $0.12
SINGAPORE–(BUSINESS WIRE)–Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) (“Kulicke & Soffa,” “K&S” or the “Company”), announced today that its Board of Directors...
- 744
Kulicke & Soffa Appoints Jeff Richardson to its Board of Directors
SINGAPORE–(BUSINESS WIRE)–Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) (“Kulicke & Soffa,” “K&S” or the “Company”) today announced the appointment of David Jeffrey...
- 760
KartRider Rush+ Surpasses 10 Million Global Downloads Within Two Weeks!
Nexon’s Thrilling Mobile Racer Adds Three New Tracks and New Character ‘Dino Ethen’ LOS ANGELES–(BUSINESS WIRE)–#kartracer–Let’s go full throttle! Today, Nexon announced...
- 760
TriLinc Global Impact Fund Makes Impact Investment in Latin America
TriLinc Global Impact Fund announced today that it recently approved a $3,250,000 term loan transaction, bringing total financing commitments as of April...
- 685
COVID-19 Case Study: Retailers Reactions in China 2020 – Lin Qingxuan, Nike, Meituan Dianping, JD.com, Alibaba, and Hema – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retailer Reactions in China: Coronavirus (COVID-19) – Case Study” report has been added to ResearchAndMarkets.com’s offering. This brief looks at...
- 708
Impact of COVID-19 on the Retail Sector in China, 2020 – Consumer Behaviour and Purchasing Patterns on Food, Non-Food, Drinks and Personal Care – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retail in China: Coronavirus (COVID-19) Country impact” report has been added to ResearchAndMarkets.com’s offering. The Coronavirus (COVID-19) country report analyses...
- 715
Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML
– Oral Presentations of the Phase 2 OPTIC Interim Analysis at the American Society of Clinical Oncology (ASCO) and the European Hematology...
- 782
Takeda Announces Compelling Data from the Phase 2 Trial of Pevonedistat Plus Azacitidine in Patients with Higher-Risk MDS
– Pevonedistat Combination Demonstrates the Potential to Double Complete Remissions and Improve Outcomes in HR-MDS, With Safety Profile Similar to Azacitidine Alone...
